SlideShare a Scribd company logo
Example – anti-psychotic drugs and venous
thromboembolism
• Some research suggests antipsychotic drugs
might be associated with an increased risk of
venous thromboembolism
– Drugs also widely prescribed for nausea, vomiting,
and vertigo
– Venous thromboembolism
• Deep vein thrombosis
• Pulmonary embolism
Example – anti-psychotic drugs and VT
• Nested case-control study examining whether
antipsychotic drugs are associated with an
increased rate of venous thromboembolism
– Examined by type of antipsychotic, potency, and dose
– (BMJ 2010;341:c4245)
Example – anti-psychotic drugs and VT
• Cohort was an open cohort of people registered
with UK general practices - QResearch
– Data have been collected over 16 years
– Includes the anonymised records of over 7 million
patients who have been registered with over 500
practices spread throughout the UK
– UK has national insurance
Example – anti-psychotic drugs and VT
• Nested case-control included time period 1996-
2007
• Cases
– All patients aged 16-100 yrs with first ever record of
venous thromboembolism
– Identified based on diagnostic codes in cohort
database
Example – anti-psychotic drugs and VT
• Controls
– Used risk-set sampling to identify controls - matched
on calendar time of the incident case
– Additionally matched on age, sex and practice
– Defined as members of the practices with no
diagnosis of venous thromboembolism up to the date
of the incident case
– Selected up to 4 controls per case (will discuss in
matching)
Example – anti-psychotic drugs and VT
• Exposure to drugs assessed with prescriptions
on or before the index date
– For anti-psychotics collected information on drug
name, formulation, dose, instructions and date
– For other drugs of concern as confounders collected
only whether they were prescribed in the 24 months
before
Example – anti-psychotic drugs and VT
• Not eligible for analysis if part of the database for
less than 24 months
– Due to inadequate exposure data
• 25,532 venous thromboembolism cases
• 89,491 controls
Example – anti-psychotic
drugs and VT
• Analysis with conditional logistic regression (due
to matching)
Example – anti-psychotic
drugs and VT
• Description of VT rates
Example – anti-psychotic drugs and VT
Example – anti-psychotic drugs and VT
• Notes on the methods in this example
– Primary study base – population defined as those
attending a set of general practices, all cases within
that population identified
– Risk-set sampling
• What does OR estimate?
Example – anti-psychotic drugs and VT
• Notes on the methods in this example
– Case-control design made collection of data on full
prescription details for all antipsychotics (drug name,
formulation, dose instructions, dates) a manageable
task
• Allowed detailed examination of anti-psychotic drugs (types,
doses, timing)
• Allowed comparison of risk between new users vs longer
term users
Example – anti-psychotic drugs and VT
• Notes on the methods in this example
– Access to the prescription data due to the larger
cohort also critical to success of the exposure
assessment
– Extensive control for confounding, however…
– For most participants could not identify the reason for
the prescription
• Underlying condition and not the drug prescribed to treat it
might be the cause of VT (confounding by indication)
• Analyses removing those with schizophrenia and bipolar
disorder did not change the results
Example – anti-psychotic drugs and VT
• Authors suggested a case-crossover design to
strengthen the evidence on anti-psychotic drugs
and VT
– What do you think of this suggestion?
Case-control studies outline
• Strengths and challenges
• Example: anti-psychotic drugs and venous thromboembolism –
nested case-control
• Example: diarrhea outbreak in India – cumulative case-control xx
• Example: hip fracture – comparison of hospital and community
controls
• Summary
Example – diarrhea outbreak in India
• On 26 September 2007, the Gayeshpur
municipality reported cluster of diarrhea cases
• Investigation conducted to identify the agent as
well as the source of infection
• Cumulative case-control design
• Saha et al. 2009 (Natl Med J India. 2009 Sep-Oct;22(5):237-9.)
Example – diarrhea outbreak in India
• Cases
– Reviewed data on diarrheal diseases available from
the municipal health office
– Defined a possible case-patient as a resident of the
Gayeshpur municipality who had diarrhea (>3 loose
stools during a 24-hour period) between September
and October 2007
– Asked healthcare workers in all facilities to report
similar new cases
– Cases for the case-control analyses met the above
definition and resided in one of 4 wards (ward
numbers 2, 5, 6 and 8)
Example – diarrhea outbreak in India
• Controls
– Were matched on age-, sex- and neighborhood to
each case
• Exposure assessment
– Municipal health workers collected information among
participants regarding demographic characteristics,
date of onset, signs and symptoms, outcome, food-
handling practices, water intake and sanitation
Example – diarrhea
outbreak in India
• Results
Example – diarrhea
outbreak in India
• Results
Example – diarrhea outbreak in India
Example – diarrhea outbreak in India
Example – diarrhea outbreak in India
• Notes on the methods in this example
– Primary study base – population defined as those
residing in one of 4 wards in Gayeshpur municipality,
all cases within that population identified
– Case-control design facilitated a rapid assessment of
differences in exposures among those with diarrheal
disease and those without
– Self-report of exposures so accuracy of recall may be
different between cases and controls
Example – diarrhea outbreak in India
• Notes on the methods in this example
– Confounding handled by matching on age, sex and
neighborhood
• To be discussed in matching module
– Concerns about other confounders?
– Problematic that OR in study estimates OR in
population and not CIR or IDR?
Example – hip fracture
• Case-control study of risk factors for hip fracture
– Comparison of results using hospital controls vs
community controls
– N Engl J Med. 1991 May 9;324(19):1326-31
Example – hip fracture
• Cases
– White and black women aged 45 years or more with
radiologically confirmed diagnosis of first hip fracture
– Selected from 30 participating hospitals in NYC and
Philadelphia 1987-1989
– Primary or secondary study base?
Example – hip fracture
• Hospital controls
– Hospitalized women from a surgical ward or an
orthopedic ward with no previous hip fracture or hip
replacement
– Frequency matched to cases by age, hospital and
race
– Admissions diagnoses included cardiovascular
disease or peripheral vascular disease, digestive
disorders, cancers, osteoarthritis and other
musculoskeletal disorders, infections
– Why might you use hospital controls?
Example – hip fracture
• Community controls
– For cases aged 65 or older, community controls were
randomly selected from the Health Care Financing
Administration lists of Medicare recipients – frequency
matched to cases on age, race and zip code
– For cases under 65 years of age, community controls
selected by random digit dialing and matched by age,
race and telephone prefix
– Why might you use community controls?
Example – hip fracture
• Exposure assessment
– In-person interviews to assess lower-extremity
function, vision, medical and surgical history, use of
medications before hospitalization, dietary and
reproductive history, height, weight, smoking, alcohol
consumption, symptoms related to balance and gait,
and sociodemographic information
– Cases and hospital controls were generally
interviewed in the hospital
– Community controls were generally interviewed in
their homes
6.6 examples
Example – hip fracture
• Associations observed were different depending
on the control group selected
– Hospital controls likely less healthy than study base
– Community controls perhaps healthier than study
base
• Comparison of community controls with
representative sample of elderly in urban
northeastern areas
– Very similar
• Conclude community controls more appropriate
Example – hip fracture
• Notes on the methods in this example
– Secondary study base – highlights challenge of
finding controls to represent secondary study base
– Case-control design provided a less resource
intensive approach to identifying risk factors, but
challenges with control group identification probably
mean a trade off with bias
– Self-report of exposures so accuracy of recall may be
different between cases and controls
• Probably less of an issue for the hospital controls than for the
community controls
Example – hip fracture
• Notes on the methods in this example
– What does OR estimate?
• Cumulative case-control so OR estimates OR in
population
– What could have been changed about the design to
have the OR estimate a different MoA?
• Matching controls on time of case occurrence
could have produced a density-sampling approach
in which OR = IDR
• However, the control groups already bringing in bias, so
perhaps perceived not to be worth the additional effort
Example – hip fracture
• Notes on the methods in this example
– With the cumulative case-control design, when does
OR approximate IDR?
• Rare disease

More Related Content

PPTX
6.7 summaries
 
PPTX
5.6 examples whi
 
PPTX
5.3 history
 
PPTX
6.2 principles
 
PPTX
6.3 sources of controls
 
PPTX
5.5 example estrogen and chd
 
PPTX
5.2 cohort studies basic approach
 
PDF
Cross sectional study
6.7 summaries
 
5.6 examples whi
 
5.3 history
 
6.2 principles
 
6.3 sources of controls
 
5.5 example estrogen and chd
 
5.2 cohort studies basic approach
 
Cross sectional study

What's hot (20)

PPT
Corss_sectional _study_ design
PPTX
3.3 hierarchy of populations
 
PDF
Cross sectional studies
PPTX
5.4 strengths and challenges
 
PPTX
Analytical epidemiology cross sectional and cohort
PPTX
Cross sectional research
PDF
PPTX
Study Session 14.pptx
PPTX
observational analytical and interventional studies
PDF
RESEARCH PROPOSAL OUTLINES RSS6 2014
PDF
Basics for beginners in statistics
PPTX
83341 ch12 jacobsen
PPTX
Medical research
PPT
Research Methodology
PDF
Case-Control Studies
PPT
Evidence Based Practice
PPTX
Case Report Writing
PPTX
Reporting guidelines
PPTX
How To Read A Medical Paper: Part 2, Assessing the Methodological Quality
PPTX
5.1 study design overview
 
Corss_sectional _study_ design
3.3 hierarchy of populations
 
Cross sectional studies
5.4 strengths and challenges
 
Analytical epidemiology cross sectional and cohort
Cross sectional research
Study Session 14.pptx
observational analytical and interventional studies
RESEARCH PROPOSAL OUTLINES RSS6 2014
Basics for beginners in statistics
83341 ch12 jacobsen
Medical research
Research Methodology
Case-Control Studies
Evidence Based Practice
Case Report Writing
Reporting guidelines
How To Read A Medical Paper: Part 2, Assessing the Methodological Quality
5.1 study design overview
 
Ad

Viewers also liked (7)

PPTX
6.4.3 designs cumulative
 
PPTX
6.5 strengths and challenges
 
PPTX
6.1 big picture
 
PPTX
6.4.2 designs case cohort
 
PPTX
6.4.1 designs density
 
PPTX
6.4.4 designs case-crossover
 
PPTX
5.7 poisson regression in the analysis of cohort data
 
6.4.3 designs cumulative
 
6.5 strengths and challenges
 
6.1 big picture
 
6.4.2 designs case cohort
 
6.4.1 designs density
 
6.4.4 designs case-crossover
 
5.7 poisson regression in the analysis of cohort data
 
Ad

Similar to 6.6 examples (20)

PPT
Case control studies.ppt
PPT
Case Control Studies
PPTX
Pharmacoepidemiology
PPTX
Study design used in pharmacoepidemiology
PDF
Pharmacoepidemiology
PPTX
Case control studies..skp
PPTX
Pharmacoepideiology
PPTX
Epidemiological Studies
PPTX
Pharmacoepidemiology (final read ) PINESH PATEL
PPT
RSS 2012 Study designs
PPTX
Case control study
PPTX
Case control study
PPTX
Ch 2 basic concepts in pharmacoepidemiology (10 hrs)
PPT
02 Study Designs - Research Methodology Workshop - Aug 2011.ppt
PPTX
Analytical study designs.pptx
PPTX
Case Control Study Design
PDF
5. Case control
PPTX
PHARMACOEPIDEMIOLOGY
DOC
Public Health Questions and Answers for Students
Case control studies.ppt
Case Control Studies
Pharmacoepidemiology
Study design used in pharmacoepidemiology
Pharmacoepidemiology
Case control studies..skp
Pharmacoepideiology
Epidemiological Studies
Pharmacoepidemiology (final read ) PINESH PATEL
RSS 2012 Study designs
Case control study
Case control study
Ch 2 basic concepts in pharmacoepidemiology (10 hrs)
02 Study Designs - Research Methodology Workshop - Aug 2011.ppt
Analytical study designs.pptx
Case Control Study Design
5. Case control
PHARMACOEPIDEMIOLOGY
Public Health Questions and Answers for Students

More from A M (20)

PDF
Transparency7
 
PDF
Transparency6
 
PDF
Transparency5
 
PDF
Transparency4
 
PDF
Transparency3
 
PDF
Transparency2
 
PDF
Transparency1
 
PPTX
5.3.5 causal inference in research
 
PPTX
5.3.4 reporting em
 
PPTX
5.3.3 potential outcomes em
 
PPTX
5.3.2 sufficient cause em
 
PPTX
5.3.1 causal em
 
PPTX
5.2.3 dags for selection bias
 
PPTX
5.2.2 dags for confounding
 
PPTX
5.1.3 hills criteria
 
PPTX
5.1.2 counterfactual framework
 
PPTX
5.1.1 sufficient component cause model
 
PPTX
5.2.1 dags
 
PPTX
4.4. effect modification
 
PPTX
4.5. logistic regression
 
Transparency7
 
Transparency6
 
Transparency5
 
Transparency4
 
Transparency3
 
Transparency2
 
Transparency1
 
5.3.5 causal inference in research
 
5.3.4 reporting em
 
5.3.3 potential outcomes em
 
5.3.2 sufficient cause em
 
5.3.1 causal em
 
5.2.3 dags for selection bias
 
5.2.2 dags for confounding
 
5.1.3 hills criteria
 
5.1.2 counterfactual framework
 
5.1.1 sufficient component cause model
 
5.2.1 dags
 
4.4. effect modification
 
4.5. logistic regression
 

Recently uploaded (20)

PPTX
1st Inaugural Professorial Lecture held on 19th February 2020 (Governance and...
PDF
Microbial disease of the cardiovascular and lymphatic systems
PPTX
Institutional Correction lecture only . . .
PDF
FourierSeries-QuestionsWithAnswers(Part-A).pdf
PPTX
Final Presentation General Medicine 03-08-2024.pptx
PPTX
Pharma ospi slides which help in ospi learning
PDF
Classroom Observation Tools for Teachers
PDF
The Lost Whites of Pakistan by Jahanzaib Mughal.pdf
PPTX
Pharmacology of Heart Failure /Pharmacotherapy of CHF
PDF
Complications of Minimal Access Surgery at WLH
PPTX
GDM (1) (1).pptx small presentation for students
PDF
grade 11-chemistry_fetena_net_5883.pdf teacher guide for all student
PDF
VCE English Exam - Section C Student Revision Booklet
PDF
A systematic review of self-coping strategies used by university students to ...
PDF
O5-L3 Freight Transport Ops (International) V1.pdf
PDF
O7-L3 Supply Chain Operations - ICLT Program
PPTX
Lesson notes of climatology university.
PDF
Chapter 2 Heredity, Prenatal Development, and Birth.pdf
PPTX
Presentation on HIE in infants and its manifestations
PPTX
Tissue processing ( HISTOPATHOLOGICAL TECHNIQUE
1st Inaugural Professorial Lecture held on 19th February 2020 (Governance and...
Microbial disease of the cardiovascular and lymphatic systems
Institutional Correction lecture only . . .
FourierSeries-QuestionsWithAnswers(Part-A).pdf
Final Presentation General Medicine 03-08-2024.pptx
Pharma ospi slides which help in ospi learning
Classroom Observation Tools for Teachers
The Lost Whites of Pakistan by Jahanzaib Mughal.pdf
Pharmacology of Heart Failure /Pharmacotherapy of CHF
Complications of Minimal Access Surgery at WLH
GDM (1) (1).pptx small presentation for students
grade 11-chemistry_fetena_net_5883.pdf teacher guide for all student
VCE English Exam - Section C Student Revision Booklet
A systematic review of self-coping strategies used by university students to ...
O5-L3 Freight Transport Ops (International) V1.pdf
O7-L3 Supply Chain Operations - ICLT Program
Lesson notes of climatology university.
Chapter 2 Heredity, Prenatal Development, and Birth.pdf
Presentation on HIE in infants and its manifestations
Tissue processing ( HISTOPATHOLOGICAL TECHNIQUE

6.6 examples

  • 1. Example – anti-psychotic drugs and venous thromboembolism • Some research suggests antipsychotic drugs might be associated with an increased risk of venous thromboembolism – Drugs also widely prescribed for nausea, vomiting, and vertigo – Venous thromboembolism • Deep vein thrombosis • Pulmonary embolism
  • 2. Example – anti-psychotic drugs and VT • Nested case-control study examining whether antipsychotic drugs are associated with an increased rate of venous thromboembolism – Examined by type of antipsychotic, potency, and dose – (BMJ 2010;341:c4245)
  • 3. Example – anti-psychotic drugs and VT • Cohort was an open cohort of people registered with UK general practices - QResearch – Data have been collected over 16 years – Includes the anonymised records of over 7 million patients who have been registered with over 500 practices spread throughout the UK – UK has national insurance
  • 4. Example – anti-psychotic drugs and VT • Nested case-control included time period 1996- 2007 • Cases – All patients aged 16-100 yrs with first ever record of venous thromboembolism – Identified based on diagnostic codes in cohort database
  • 5. Example – anti-psychotic drugs and VT • Controls – Used risk-set sampling to identify controls - matched on calendar time of the incident case – Additionally matched on age, sex and practice – Defined as members of the practices with no diagnosis of venous thromboembolism up to the date of the incident case – Selected up to 4 controls per case (will discuss in matching)
  • 6. Example – anti-psychotic drugs and VT • Exposure to drugs assessed with prescriptions on or before the index date – For anti-psychotics collected information on drug name, formulation, dose, instructions and date – For other drugs of concern as confounders collected only whether they were prescribed in the 24 months before
  • 7. Example – anti-psychotic drugs and VT • Not eligible for analysis if part of the database for less than 24 months – Due to inadequate exposure data • 25,532 venous thromboembolism cases • 89,491 controls
  • 8. Example – anti-psychotic drugs and VT • Analysis with conditional logistic regression (due to matching)
  • 9. Example – anti-psychotic drugs and VT • Description of VT rates
  • 11. Example – anti-psychotic drugs and VT • Notes on the methods in this example – Primary study base – population defined as those attending a set of general practices, all cases within that population identified – Risk-set sampling • What does OR estimate?
  • 12. Example – anti-psychotic drugs and VT • Notes on the methods in this example – Case-control design made collection of data on full prescription details for all antipsychotics (drug name, formulation, dose instructions, dates) a manageable task • Allowed detailed examination of anti-psychotic drugs (types, doses, timing) • Allowed comparison of risk between new users vs longer term users
  • 13. Example – anti-psychotic drugs and VT • Notes on the methods in this example – Access to the prescription data due to the larger cohort also critical to success of the exposure assessment – Extensive control for confounding, however… – For most participants could not identify the reason for the prescription • Underlying condition and not the drug prescribed to treat it might be the cause of VT (confounding by indication) • Analyses removing those with schizophrenia and bipolar disorder did not change the results
  • 14. Example – anti-psychotic drugs and VT • Authors suggested a case-crossover design to strengthen the evidence on anti-psychotic drugs and VT – What do you think of this suggestion?
  • 15. Case-control studies outline • Strengths and challenges • Example: anti-psychotic drugs and venous thromboembolism – nested case-control • Example: diarrhea outbreak in India – cumulative case-control xx • Example: hip fracture – comparison of hospital and community controls • Summary
  • 16. Example – diarrhea outbreak in India • On 26 September 2007, the Gayeshpur municipality reported cluster of diarrhea cases • Investigation conducted to identify the agent as well as the source of infection • Cumulative case-control design • Saha et al. 2009 (Natl Med J India. 2009 Sep-Oct;22(5):237-9.)
  • 17. Example – diarrhea outbreak in India • Cases – Reviewed data on diarrheal diseases available from the municipal health office – Defined a possible case-patient as a resident of the Gayeshpur municipality who had diarrhea (>3 loose stools during a 24-hour period) between September and October 2007 – Asked healthcare workers in all facilities to report similar new cases – Cases for the case-control analyses met the above definition and resided in one of 4 wards (ward numbers 2, 5, 6 and 8)
  • 18. Example – diarrhea outbreak in India • Controls – Were matched on age-, sex- and neighborhood to each case • Exposure assessment – Municipal health workers collected information among participants regarding demographic characteristics, date of onset, signs and symptoms, outcome, food- handling practices, water intake and sanitation
  • 19. Example – diarrhea outbreak in India • Results
  • 20. Example – diarrhea outbreak in India • Results
  • 21. Example – diarrhea outbreak in India
  • 22. Example – diarrhea outbreak in India
  • 23. Example – diarrhea outbreak in India • Notes on the methods in this example – Primary study base – population defined as those residing in one of 4 wards in Gayeshpur municipality, all cases within that population identified – Case-control design facilitated a rapid assessment of differences in exposures among those with diarrheal disease and those without – Self-report of exposures so accuracy of recall may be different between cases and controls
  • 24. Example – diarrhea outbreak in India • Notes on the methods in this example – Confounding handled by matching on age, sex and neighborhood • To be discussed in matching module – Concerns about other confounders? – Problematic that OR in study estimates OR in population and not CIR or IDR?
  • 25. Example – hip fracture • Case-control study of risk factors for hip fracture – Comparison of results using hospital controls vs community controls – N Engl J Med. 1991 May 9;324(19):1326-31
  • 26. Example – hip fracture • Cases – White and black women aged 45 years or more with radiologically confirmed diagnosis of first hip fracture – Selected from 30 participating hospitals in NYC and Philadelphia 1987-1989 – Primary or secondary study base?
  • 27. Example – hip fracture • Hospital controls – Hospitalized women from a surgical ward or an orthopedic ward with no previous hip fracture or hip replacement – Frequency matched to cases by age, hospital and race – Admissions diagnoses included cardiovascular disease or peripheral vascular disease, digestive disorders, cancers, osteoarthritis and other musculoskeletal disorders, infections – Why might you use hospital controls?
  • 28. Example – hip fracture • Community controls – For cases aged 65 or older, community controls were randomly selected from the Health Care Financing Administration lists of Medicare recipients – frequency matched to cases on age, race and zip code – For cases under 65 years of age, community controls selected by random digit dialing and matched by age, race and telephone prefix – Why might you use community controls?
  • 29. Example – hip fracture • Exposure assessment – In-person interviews to assess lower-extremity function, vision, medical and surgical history, use of medications before hospitalization, dietary and reproductive history, height, weight, smoking, alcohol consumption, symptoms related to balance and gait, and sociodemographic information – Cases and hospital controls were generally interviewed in the hospital – Community controls were generally interviewed in their homes
  • 31. Example – hip fracture • Associations observed were different depending on the control group selected – Hospital controls likely less healthy than study base – Community controls perhaps healthier than study base • Comparison of community controls with representative sample of elderly in urban northeastern areas – Very similar • Conclude community controls more appropriate
  • 32. Example – hip fracture • Notes on the methods in this example – Secondary study base – highlights challenge of finding controls to represent secondary study base – Case-control design provided a less resource intensive approach to identifying risk factors, but challenges with control group identification probably mean a trade off with bias – Self-report of exposures so accuracy of recall may be different between cases and controls • Probably less of an issue for the hospital controls than for the community controls
  • 33. Example – hip fracture • Notes on the methods in this example – What does OR estimate? • Cumulative case-control so OR estimates OR in population – What could have been changed about the design to have the OR estimate a different MoA? • Matching controls on time of case occurrence could have produced a density-sampling approach in which OR = IDR • However, the control groups already bringing in bias, so perhaps perceived not to be worth the additional effort
  • 34. Example – hip fracture • Notes on the methods in this example – With the cumulative case-control design, when does OR approximate IDR? • Rare disease